Guggenheim Reiterates Buy Rating on Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP)

Guggenheim analysts reiterated a Buy rating on Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (NASDAQ:BRKRP) on January 26, 2026.

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A operates in the Healthcare sector. The stock currently trades at $376.01 with a market capitalization of $54.4B.